FoxP3: A genetic link between immunodeficiency and autoimmune diseases

Autoimmunity Reviews

Volumn 5, Issue 6, 2006, Pages 399-402

  Chang, Xing ^a   Zheng, Pan ^a   Liu, Yang ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Homeostatic proliferation; IPEX; Scurfy; Thymopoiesis

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

AUTOIMMUNE DISEASE; BONE MARROW; CD4+ CD25+ T LYMPHOCYTE; CELL PROLIFERATION; DISEASE SEVERITY; ENVIRONMENT; GENE MUTATION; GENETIC LINKAGE; HEMATOPOIETIC CELL; HUMAN; IMMUNE DEFICIENCY; LYMPHOCYTOPENIA; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE;

ANIMALS; AUTOIMMUNE DISEASES; FORKHEAD TRANSCRIPTION FACTORS; GENETIC DISEASES, X-LINKED; GENETIC DISEASES, Y-LINKED; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; MICE; MODELS, IMMUNOLOGICAL; MUTATION; T-LYMPHOCYTES; THYMUS GLAND;

EID: 33746581243     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2005.10.008     Document Type: Review

References (36)

1. Kratz C.P., Niehues T., Lyding S., Heusch A., Janssen G., and Gobel U. Evans syndrome in a patient with chromosome 22q11.2 deletion syndrome: a case report. Pediatr Hematol Oncol 20 (2003) 167-172
2. Pelkonen P., Lahdenne P., Lantto R., and Honkanen V. Chronic arthritis associated with chromosome deletion 22q11.2 syndrome. J Rheumatol 29 (2002) 2648-2650
3. Davies K., Stiehm E.R., Woo P., and Murray K.J. Juvenile idiopathic polyarticular arthritis and IgA deficiency in the 22q11 deletion syndrome. J Rheumatol 28 (2001) 2326-2334
4. Kawamura T., Nimura I., Hanafusa M., Fujikawa R., Okubo M., Egusa G., et al. DiGeorge syndrome with Graves' disease: a case report. Endocr J 47 (2000) 91-95
5. Sullivan K.E., McDonald-McGinn D.M., Driscoll D.A., Zmijewski C.M., Ellabban A.S., Reed L., et al. Juvenile rheumatoid arthritis-like polyarthritis in chromosome 22q11.2 deletion syndrome (DiGeorge anomalad/velocardiofacial syndrome/conotruncal anomaly face syndrome). Arthritis Rheum 40 (1997) 430-436
6. Goldrath A.W., and Bevan M.J. Low-affinity ligands for the TCR drive proliferation of mature CD8+ T cells in lymphopenic hosts. Immunity 11 (1999) 183-190
7. Goldrath A.W., Bogatzki L.Y., and Bevan M.J. Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J Exp Med 192 (2000) 557-564
8. Cho B.K., Rao V.P., Ge Q., Eisen H.N., and Chen J. Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells. J Exp Med 192 (2000) 549-556
9. King C., Ilic A., Koelsch K., and Sarvetnick N. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 117 (2004) 265-277
10. Gallegos A.M., and Bevan M.J. Driven to autoimmunity: the nod mouse. Cell 117 (2004) 149-151
11. Dudley M.E., Wunderlich J.R., Robbins P.F., Yang J.C., Hwu P., Schwartzentruber D.J., et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298 (2002) 850-854
12. Godfrey V.L., Wilkinson J.E., and Russell L.B. X-linked lymphoreticular disease in the scurfy (sf) mutant mouse. Am J Pathol 138 (1991) 1379-1387
13. Blair P.J., Bultman S.J., Haas J.C., Rouse B.T., Wilkinson J.E., and Godfrey V.L. CD4+CD8- T cells are the effector cells in disease pathogenesis in the scurfy (sf) mouse. J Immunol 153 (1994) 3764-3774
14. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., Yasayko S.A., et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 27 (2001) 68-73
15. Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27 (2001) 20-21
16. Chatila T.A., Blaeser F., Ho N., Lederman H.M., Voulgaropoulos C., Helms C., et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 106 (2000) R75-R81
17. Wildin R.S., Smyk-Pearson S., and Filipovich A.H. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 39 (2002) 537-545
18. Wildin R.S., Ramsdell F., Peake J., Faravelli F., Casanova J.L., Buist N., et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27 (2001) 18-20
19. Khattri R., Cox T., Yasayko S.A., and Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 4 (2003) 337-342
20. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
21. Fontenot J.D., Gavin M.A., and Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4 (2003) 330-336
22. Khattri R., Kasprowicz D., Cox T., Mortrud M., Appleby M.W., Brunkow M.E., et al. The amount of scurfin protein determines peripheral T cell number and responsiveness. J Immunol 167 (2001) 6312-6320
23. Godfrey V.L., Wilkinson J.E., Rinchik E.M., and Russell L.B. Fatal lymphoreticular disease in the scurfy (sf) mouse requires T cells that mature in a sf thymic environment: potential model for thymic education. Proc Natl Acad Sci U S A 88 (1991) 5528-5532
24. Sano S., Takahama Y., Sugawara T., Kosaka H., Itami S., Yoshikawa K., et al. Stat3 in thymic epithelial cells is essential for postnatal maintenance of thymic architecture and thymocyte survival. Immunity 15 (2001) 261-273
25. Chang X., Gao J.X., Jiang Q., Wen J., Seifers N., Su L., et al. The scurfy mutation of FoxP3 in the thymus stroma leads to defective thymopoiesis. J Exp Med 202 (2005) 1141-1151
26. Fontenot J.D., Rasmussen J.P., Williams L.M., Dooley J.L., Farr A.G., and Rudensky A.Y. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22 (2005) 329-341
27. Davis S., and Schumacher M.J. Myasthenia gravis and lymphoma. A clinical and immunological association. JAMA 242 (1979) 2096-2097
28. Gerli R., Paganelli R., Cossarizza A., Muscat C., Piccolo G., Barbieri D., et al. Long-term immunologic effects of thymectomy in patients with myasthenia gravis. J Allergy Clin Immunol 103 (1999) 865-872
29. Bloomfield S., Stockdill G., and Barnetson R.S. Thymic hypoplasia, auto-immune haemolytic anaemia and juvenile pemphigoid in an infant. Br J Dermatol 106 (1982) 353-355
30. Goronzy J.J., and Weyand C.M. Thymic function and peripheral T-cell homeostasis in rheumatoid arthritis. Trends Immunol 22 (2001) 251-255
31. Hug A., Korporal M., Schroder I., Haas J., Glatz K., Storch-Hagenlocher B., et al. Thymic export function and T cell homeostasis in patients with relapsing remitting multiple sclerosis. J Immunol 171 (2003) 432-437
32. MacMurray A.J.M.D., Kwitek A.E., Rutledge E.A., Van Yserloo B., Gohlke P., Speros S.J., et al. Lymphopenia in the BB rat model of type 1 diabetes is due to a mutation in a novel immune-associated nucleotide (Ian)-related gene. Genome Res 12 (2002) 1029-1039
33. Hornum L., Romer J., and Markholst H. The diabetes-prone BB rat carries a frameshift mutation in Ian4, a positional candidate of Iddm1. Diabetes 51 (2002) 1972-1979
34. Wagner U., Pierer M., Wahle M., Moritz F., Kaltenhauser S., and Hantzschel H. Ex vivo homeostatic proliferation of CD4+ T cells in rheumatoid arthritis is dysregulated and driven by membrane-anchored TNFalpha. J Immunol 173 (2004) 2825-2833
35. Kao A.H., Manzi S., and Ramsey-Goldman R. Review of ACR hematologic criteria in systemic lupus erythematosus. Lupus 13 (2004) 865-868
36. Lawson B.R., Koundouris S.I., Barnhouse M., Dummer W., Baccala R., Kono D.H., et al. The role of alpha beta+ T cells and homeostatic T cell proliferation in Y-chromosome-associated murine lupus. J Immunol 167 (2001) 2354-2360